Intercept Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Intercept Pharmaceuticals

01/11/2022 13:33

* Intercept Pharmaceuticals Inc  ICPT.OQ  reported quarterly
adjusted earnings of $7.80​​ per share for the quarter ended in
September. The mean expectation of sixteen analysts for the
quarter was for earnings of $4.61 per share.
    * Revenue fell 16.4% to $77.59 million from a year ago;
analysts
expected $74.07 million. 
    * Intercept Pharmaceuticals Inc's reported EPS for the
quarter was
$7.80​.
    * The mean earnings estimate of analysts had risen by
about 20.2%
in the last three months.​ 
    * In the last 30 days three analysts negatively revised
earnings
estimates 
    * Intercept Pharmaceuticals Inc shares had fallen by 0.6%
this
quarter and lost 14.9% so far this year.
    * The company reported quarterly net income of $267.45
million.
    * Wall Street's median 12-month price target for Intercept
Pharmaceuticals Inc is $22.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 9
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
1 at 01:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      4.61           7.80           Beat
 Jun. 30 2022      -0.49          -0.68          Missed
 Mar. 31 2022      -0.90          -0.58          Beat
 Dec. 31 2021      -1.10          -1.23          Missed